WallStreet-PR News Releases

NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches

Wed, 21 Oct 2026 10:17:00 -0400

Compassionate care for children in Abu Dhabi, a new research MoU and a senior banking appointment add momentum to NeOnc's development story Houston, Texas--(Newsfile Corp. - October 21, 2026) - As NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) prepares for an upcoming FDA meeting, its work in Abu Dhabi is bringing that human side of biotechnology into focus.Technology today can feel like magic. For families confronting a child's brain cancer, the hope that medical science might accomplish...

NeOnc's Most Challenging Test Yet: Compassionate-Use Update Puts NEO100's Potential in Focus

Fri, 16 Oct 2026 09:27:00 -0400

Pediatric Case, Abu Dhabi Expansion and Board Appointment Highlight a Broader Development Strategy Houston, Texas--(Newsfile Corp. - October 16, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) is confronting one of the most consequential tests of its investigational brain-cancer platform as it pursues treatment options for patients facing some of the most difficult challenges in neuro-oncology. The company recently reported an early clinical update involving a critically ill three-year-old...

Indistinguishable From Magic: How Kraig Labs Brought Spider Silk into Reality

Tue, 06 Oct 2026 10:17:00 -0400

Genetically engineered silkworms have delivered a commercial yarn shipment. Project Atlas is exploring what those tiny silk factories could produce next. Houston, Texas--(Newsfile Corp. - October 6, 2026) - Wall Street PR www.wallstreet-pr.com A silkworm feeding on mulberry leaves hardly looks like the beginning of a materials revolution. Yet inside Kraig Biocraft Laboratories' (OTCQB: KBLB) engineered silkworms, rewritten genetic instructions enable an extraordinary task: producing silk that...

Kraig Labs Opens the Global Market for Its Spider Silk with Historic Multi-Kilogram Order

Tue, 29 Sep 2026 08:15:00 -0400

First commercial spider silk yarn shipment for a global performance sports brand marks a milestone alongside record production and Project Atlas advances Houston, Texas--(Newsfile Corp. - September 29, 2026) - Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) has shipped a historic multi-kilogram order of recombinant spider silk yarn for a globally recognized performance sports brand, marking the Company's first remunerated commercial yarn shipment.The custom-engineered yarn was produced to...

NeOnc's NEO100 Phase 2a Brain Cancer Study Beats Historical Benchmark by Nearly 2.5x

Wed, 12 Aug 2026 09:25:00 -0400

Phase 2a results showed 48.9% six-month progression-free survival versus a 20% historical benchmark, with median overall survival reaching approximately 26 months Houston, Texas--(Newsfile Corp. - August 12, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) reported encouraging Phase 2a results for intranasal NEO100 in patients with recurrent IDH1-mutant high-grade glioma, showing a 48.9% six-month progression-free survival rate compared with a 20% historical benchmark.The result was nearly 2.5...

NTHI Brain Cancer Phase 2 Data Expected to Spark Triple Confluence

Tue, 11 Aug 2026 08:44:00 -0400

Houston, Texas--(Newsfile Corp. - August 11, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) is set up for a potential high impact catalyst day with what market observers are describing as a classic triple confluence setup.The company will release topline Phase 2a results for its intranasal NEO100 therapy in recurrent IDH1-mutant high-grade glioma, a difficult-to-treat form of brain cancer on Wednesday, August 12 at 8:30 a.m. ET.The three factors market participants should watch are its...

WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy

Mon, 22 Jun 2026 08:45:00 -0400

International Regulatory Validation Has Preceded Several Recent FDA Success Stories, Though Significant Development Risks Remain Houston, Texas--(Newsfile Corp. - June 22, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) recently achieved what many biotechnology companies spend years attempting to secure: international regulatory validation for a novel therapeutic candidate before obtaining later-stage U.S. approvals.The Department of Health - Abu Dhabi's Investigational New Drug (IND)...

WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates

Mon, 15 Jun 2026 08:35:00 -0400

New Funding Structure Includes Redemption Rights, Ownership Limitations, and Conversion Floor as Investors Monitor Upcoming Clinical Updates Houston, Texas--(Newsfile Corp. - June 15, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) continues to attract attention within the biotechnology sector as the Company advances its neuro-oncology pipeline and strengthens its balance sheet ahead of anticipated clinical development milestones.NeOnc's new Securities Purchase Agreement with accredited...

The Race to Defeat Brain Cancer Could Become One of the Biggest Biotech Stories of the Decade

Tue, 09 Jun 2026 08:45:00 -0400

NeOnc Technologies Advances Novel Neuro-Oncology Therapies Targeting Glioblastoma and Other Hard-to-Treat Brain Cancers Houston, Texas--(Newsfile Corp. - June 9, 2026) - For years, artificial intelligence has dominated conversations surrounding the future of healthcare innovation. Yet beyond the AI-driven headlines, another potentially groundbreaking revolution is unfolding in one of medicine's most challenging arenas: the fight against brain cancer. As researchers pursue new approaches to treat...